CANCELLATION OF THE REPURCHASED H SHARES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.CANCELLATION OF THE REPURCHASED H SHARES Reference is made to the circular (the “Circular”) dated 18 November 2023 and the announcements dated 30 October 2023 and 19 December 2023 of 丽珠医药集团股份有限公司 Livzon Pharmaceutical Group Inc.* (the “Company” together with its subsidiaries the “Group”) in relation to the grant of general mandate to the Board to repurchase H shares of the Company (the “H Share Repurchase Mandate”) and the next day disclosure return dated 7 January 2024 10 January 2024 11 January 2024 16 January 2024 17 January 2024 18 January 2024 22 January 2024 23 January 2024 26 January 2024 29 January 2024 31 January 2024 5 February 2024 24 April 2024 and 25 April 2024. Unless otherwise defined capitalised terms used in this announcement shall have the same meanings as those defined in the Circular.As at 27 June 2024 the Company made a total repurchase of 2778800 H Shares of the Company accounting for 0.30% of the total issued share capital and 0.90% of the total number of issued H Shares of the Company on 27 June 2024. The highest purchase price was HK$26.15 per share and the lowest purchase price was HK$23.05 per share. Total amount of funds used was HK$68157390.00 (excluding transaction costs). The share repurchase mentioned above complies with the H Share Repurchase Mandate. 1On 28 June 2024 the Repurchased H Shares were cancelled and the registered capital of the Company will be reduced by RMB2778800.00. The Company will go through relevant registration formalities of the change as soon as possible.By order of the Board丽珠医药集团股份有限公司 ＊ Livzon Pharmaceutical Group Inc.Yang Liang Company Secretary Zhuhai China 28 June 2024 As at the date of this announcement the Executive Directors of the Company are Mr. Tang Yanggang (President) and Mr. Xu Guoxiang (Vice Chairman and Vice President); the Non-Executive Directors of the Company are Mr. Zhu Baoguo (Chairman) Mr. Tao Desheng (Vice Chairman) Mr. Qiu Qingfeng and Mr. Yu Xiong; and the Independent Non-Executive Directors of the Company are Mr. Bai Hua Mr.Tian Qiusheng Mr. Wong Kam Wa Mr. Luo Huiyuan and Ms. Cui Lijie.* For identification purpose only 2